JAMA Dermatology : Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis
Interview with Paul Nghiem, MD, PhD, author of Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis. Hosted by Adewole S. Adamson, MD, MPP. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 23, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

Velocity Vlog: Advances in Merkel Cell Carcinoma - New Treatment Approaches
In this Velocity Vlog activity, Dr. Howard L. Kaufman of the Rutgers Cancer Institute contextualizes updates to the standard of care, relays the latest developments in immunotherapy, and offers insig... Author: imedex Added: 10/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2017 Category: Cancer & Oncology Source Type: podcasts

Velocity Vlog: Advances in Merkel Cell Carcinoma - Annual Meeting 2017 Update
In this Velocity Vlog activity, Dr. Howard L. Kaufman of the Rutgers Cancer Institute, provides a brief overview of the incidence and epidemiology of Merkel cell carcinoma and then discusses clinical... Author: imedex Added: 07/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - July 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Velocity Vlog: Advances in Merkel Cell Carcinoma - ASCO 2017 Update
In this Velocity Vlog activity, Dr. Howard L. Kaufman of the Rutgers Cancer Institute, provides a brief overview of the incidence and epidemiology of Merkel cell carcinoma and then discusses clinical... Author: imedex Added: 07/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - July 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Abstract Overview: T-Cell Therapy for Merkel Cell Carcinoma
Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance gives an overview and background context on her abstract which focuses on t-cell therapy merkel cell carcinoma. This was recorded at the 2017... Author: ASCO2017 Added: 06/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2017 Category: Cancer & Oncology Source Type: podcasts

Whats Next for T-Cell Therapy and Avelumab for Merkel Cell Carcinoma
Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance discusses what's next in the future for her clinical trial on t-cell therapy and avelumab for merkel cell carcinoma at the 2017 ASCO Annual M... Author: ASCO2017 Added: 06/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2017 Category: Cancer & Oncology Source Type: podcasts

Epitopes of Merkel Cell Polyomavirus
Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance explains what epitopes are in merkel cell carcinoma. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL. Author: ASCO2017 Added: 06/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2017 Category: Cancer & Oncology Source Type: podcasts

Cellular Immunotherapy for Merkel Cell Carcinoma
Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance gives an overview of her poster presentation which focuses on two trials of cellular immunotherapy for merkel cell carcinoma. This was record... Author: ASCO2017 Added: 06/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2017 Category: Cancer & Oncology Source Type: podcasts

Importance of Checkpoint Inhibitors in Merkel Cell Cancers
Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center explains the importance of checkpoint inhibitors, specifically avelumab, in merkel cell cancers. This was recorded at the Am... Author: aacr2017 Added: 04/28/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 28, 2017 Category: Cancer & Oncology Source Type: podcasts

JAVELIN Merkel 200: Results of Phase II Study for Merkel Cell Carcinoma
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey gives an overview of his current research, a phase II study which involved a newly FDA-approved drug, avelumab, in patients with m... Author: aacr2017 Added: 04/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 27, 2017 Category: Cancer & Oncology Source Type: podcasts

Future Research Will Involve Combination Studies for Merkel Cell Carcinoma
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey explains the impact of data on future research, stating that avelumab is the only FDA approved drug for Merkel Cell Carcinoma, and... Author: aacr2017 Added: 04/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 27, 2017 Category: Cancer & Oncology Source Type: podcasts

Avelumab: New Agent Available for Merkel Cell Carcinoma
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey discusses the use of avelumab, a new agent that became available for patients with merkel cell carcinoma. This was recorded at the... Author: aacr2017 Added: 04/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 27, 2017 Category: Cancer & Oncology Source Type: podcasts

AACR 2017 Presentations Focus on Merkel Cell Carcinoma, Triple-Negative Breast Cancer, & amp; Immunotherapy in Melanoma
Julie Brahmer, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives an overview of some of the presentations that were discussed at AACR 2017. She states that these presentations range from Me... Author: aacr2017 Added: 04/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 19, 2017 Category: Cancer & Oncology Source Type: podcasts

AACR 2017 Presentations Focus on Merkel Cell Carcinoma, Triple-Negative Breast Cancer, & amp; Immunotherapy in Melanoma 1
Julie Brahmer, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives an overview of some of the presentations that were discussed at AACR 2017. She states that these presentations range from Me... Author: aacr2017 Added: 04/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 19, 2017 Category: Cancer & Oncology Source Type: podcasts

Open questions in the dermatopathology of cutaneous tumors - desmoplastic melanoma, spitzoid melanocytic neoplasms and Merkel cell carcinoma
Martin Mihm, Jr., MD of Brigham and Women's Hospital, Boston, MA gives an overview of the session on open quesions in dermatopahtology of cutaneous tumors held at the World Congress on Cancers of the ... Author: VJOncology Added: 10/06/2016 (Source: Oncology Tube)
Source: Oncology Tube - October 6, 2016 Category: Cancer & Oncology Source Type: podcasts